Skip to main content

Recombinant Human ADAMTS4 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 4307-AD

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
4307-AD-020

Key Product Details

Source

CHO

Accession #

Structure / Form

Recombinant Human ADAMTS4 is prone to proteolytic cleavage at C-terminus. The predominant form of the purified protein lacks the His tag.

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human ADAMTS4 protein
Phe213-Cys685, with a C-terminal 10-His tag

Purity

>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Phe213

Predicted Molecular Mass

53 kDa

SDS-PAGE

58 kDa, reducing conditions

Activity

Measured by its ability to cleave the fluorogenic peptide substrate, Abz-TEGEARGSVI-Dap(Dnp)-KK-NH2.
The specific activity is >7 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation and Storage

4307-AD
Formulation Supplied as a 0.2 μm filtered solution in Sodium Acetate, CaCl2 and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: ADAMTS4

ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4), also known as aggrecanase-1, is a member of the family of secreted zinc proteases with a multi-domain structure (1-3). The protein precursors consist of a signal peptide and the following domains: pro, catalytic, disintegrin-like, TS type 1 motif, cysteine-rich, and spacer. It is the only ADAMTS identified that has one TS type I motif. It is an active protease effectively cleaving alpha-2-macroglobulin and aggrecan at multiple sites, and is inhibited by TIMP-3 with inhibition constants in subnanomolar range (4-6). It receives great attention due to the elevation in its mRNA level after treatment with Interleukin-1 (7). However, in a mouse model of osteoarthritis, ADAMTS4 knock-out mice did not exhibit any significant protective effect (8). The purified rhADAMTS4 starts at the catalytic domain and ends before the spacer domain. If desired, the aggrecanase activity can be inhibited by 5 mM 1 10‑phenanthroline and Recombinant Human TIMP‑3 (Catalog # http://www.rndsystems.com/product_results.aspx?k=973-TM">973-TM) .

References

  1. Totorella, M. D. et al. (1999) Science 284:1664.
  2. Porter, S. et al. (2005) Biochem. J. 386:15.
  3. Nagase, H. and M. Kashiwagi (2003) Arthritis Res. Ther. 5:94.
  4. Tortorella, M. D. et al. (2004) J. Biol. Chem. 279:17554.
  5. Struglics, A. et al. (2006) Osteoarthritis Cartilage. 14:101.
  6. Kashiwagi, M. et al. (2001) J. Biol. Chem. 276:12501.
  7. Pratta, M. A. et al. (2003) Arthritis Reum. 48:119.
  8. Glasson, S. S. et al. (2004) Arthritis Reum. 50:2547.

Long Name

A Disintegrin-like and Metalloproteinase Domain with Thrombospondin Motifs 4

Alternate Names

ADMP-1, Aggrecanase 1

Entrez Gene IDs

9507 (Human); 66015 (Rat)

Gene Symbol

ADAMTS4

UniProt

Additional ADAMTS4 Products

Product Documents for Recombinant Human ADAMTS4 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human ADAMTS4 Protein, CF

For research use only

Loading...
Loading...
Loading...